RXO, Inc. (NYSE:RXO) Receives Average Recommendation of “Hold” from Analysts

Shares of RXO, Inc. (NYSE:RXOGet Free Report) have been assigned an average recommendation of “Hold” from the seventeen ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation and four have given a buy recommendation to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $25.80.

Several research firms have issued reports on RXO. Benchmark reissued a “hold” rating on shares of RXO in a research note on Wednesday, January 15th. Wells Fargo & Company cut their price objective on RXO from $31.00 to $28.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 7th. Morgan Stanley decreased their target price on shares of RXO from $27.00 to $25.00 and set an “equal weight” rating on the stock in a research report on Thursday, February 6th. Stifel Nicolaus dropped their price target on shares of RXO from $27.00 to $24.00 and set a “hold” rating for the company in a research report on Thursday, February 6th. Finally, Truist Financial started coverage on shares of RXO in a report on Thursday, March 13th. They issued a “buy” rating and a $24.00 price objective on the stock.

View Our Latest Analysis on RXO

RXO Trading Up 0.8 %

Shares of RXO opened at $18.96 on Friday. RXO has a 12-month low of $17.50 and a 12-month high of $32.82. The firm has a market capitalization of $3.10 billion, a P/E ratio of -8.94, a P/E/G ratio of 4.55 and a beta of 1.67. The firm has a 50-day moving average price of $22.03 and a 200 day moving average price of $25.56. The company has a current ratio of 1.26, a quick ratio of 1.33 and a debt-to-equity ratio of 0.22.

RXO (NYSE:RXOGet Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share for the quarter, meeting the consensus estimate of $0.06. RXO had a negative net margin of 6.26% and a positive return on equity of 1.53%. Sell-side analysts forecast that RXO will post 0.31 EPS for the current year.

Institutional Investors Weigh In On RXO

Hedge funds have recently bought and sold shares of the stock. Wilmington Savings Fund Society FSB purchased a new stake in shares of RXO during the third quarter worth approximately $28,000. Blue Trust Inc. increased its position in shares of RXO by 79.7% in the 4th quarter. Blue Trust Inc. now owns 1,150 shares of the company’s stock valued at $27,000 after purchasing an additional 510 shares during the last quarter. Smartleaf Asset Management LLC increased its position in shares of RXO by 228.4% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,248 shares of the company’s stock valued at $30,000 after purchasing an additional 868 shares during the last quarter. Nomura Asset Management Co. Ltd. raised its holdings in shares of RXO by 68.7% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock valued at $39,000 after purchasing an additional 570 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. lifted its position in shares of RXO by 407.0% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company’s stock worth $43,000 after purchasing an additional 1,445 shares during the last quarter. Institutional investors and hedge funds own 92.73% of the company’s stock.

About RXO

(Get Free Report

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Recommended Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.